Successful therapeutic strategies for the treatment of bone metastases include radium 223, bisphosphonates, and receptor activator of nuclear factor kappa-B ligand (RANKL) inhibitor denosumab
Both methods work well according to clinical knowledge, but peoples comfort and reactions are not always the same
The manufacturers of Wegovy, primarily Novo Nordisk, are facing a growing number of lawsuits alleging that the company failed to adequately warn users about serious and potentially life-altering side effects associated with the drug
Common side effects during the transition period During the switch, common side effects are still gastrointestinal in nature, such as nausea, vomiting, and diarrhea
10.1016/j.bbamem.2022.184027 38 HurE